Growth Metrics

Nexgel (NXGL) Operating Expenses (2018 - 2025)

Nexgel (NXGL) has disclosed Operating Expenses for 8 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 1.29% year-over-year to $2.0 million, compared with a TTM value of $7.4 million through Sep 2025, up 36.57%, and an annual FY2024 reading of $6.3 million, up 63.65% over the prior year.
  • Operating Expenses was $2.0 million for Q3 2025 at Nexgel, up from $1.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.0 million in Q3 2025 and bottomed at $478000.0 in Q1 2021.
  • Average Operating Expenses over 5 years is $1.1 million, with a median of $990000.0 recorded in 2021.
  • The sharpest move saw Operating Expenses soared 114.29% in 2022, then fell 19.32% in 2023.
  • Year by year, Operating Expenses stood at $990000.0 in 2021, then decreased by 17.47% to $817000.0 in 2022, then skyrocketed by 38.56% to $1.1 million in 2023, then skyrocketed by 43.11% to $1.6 million in 2024, then rose by 21.48% to $2.0 million in 2025.
  • Business Quant data shows Operating Expenses for NXGL at $2.0 million in Q3 2025, $1.9 million in Q2 2025, and $2.0 million in Q1 2025.